Funded Startups in Southlake
Among the 9 most recent funded startups listed for Southlake, Texas, one disclosed round stands far above the rest: Principal Mineral’s $280M round on 2026…
Among the 9 most recent funded startups listed for Southlake, Texas, one disclosed round stands far above the rest: Principal Mineral’s $280M round on 2026-06-16 dwarfs the next-highest disclosed amount of $75M (Renegade Insurance on 2022-04-03). Sector and stage are also concentrated: Biotechnology shows up 3 times (Renibus Therapeutics in 2023-09-12 for $25M; Onconano Medicine in 2021-10-25 for $18M and 2021-06-17 for $50M), while Seed rounds recur multiple times (Profit on 2023-06-01 for $980K; ARTFLLY on 2021-04-15 for $500K; truMED on 2021-04-14 for $500K; Mindzie on 2021-01-05 for $2M).
The dates create a cluster in 2021–2023 rather than a steady cadence, with 5 of 9 rounds landing between 2021-04-14 and 2023-09-12. The list spans 2021-01-05 (Mindzie) through 2026-06-16 (Principal Mineral), and the “Series Unknown” classification appears 2 times (Principal Mineral on 2026-06-16 for $280M; Renegade Insurance labeled “Venture - Series Unknown” on 2022-04-03 for $75M).
Most recent rounds
9 shownRelated listings
Frequently asked
What is the largest disclosed round in Southlake here, and how isolated is it versus the rest?
Principal Mineral’s $280M round on 2026-06-16 is the only disclosed amount in the $100M+ range, with the next-highest disclosed round at $75M for Renegade Insurance on 2022-04-03.
Do the rounds cluster in a narrow time window, or are they spread out evenly?
They cluster around 2021–2023: 5 of the 9 listed rounds occur between 2021-04-14 (truMED) and 2023-09-12 (Renibus Therapeutics). The earliest date shown is 2021-01-05 (Mindzie), while the most recent is 2026-06-16 (Principal Mineral).
Are any sectors over-represented compared to the others in this Southlake list?
Biotechnology is the clearest concentration with 3 entries: Renibus Therapeutics ($25M, 2023-09-12) and Onconano Medicine ($50M on 2021-06-17; $18M on 2021-10-25). Other sectors appear fewer times, such as Financial Services with 2 entries (Profit at $980K on 2023-06-01; Renegade Insurance at $75M on 2022-04-03).
How does stage classification break down across these 9 rows?
Seed appears 4 times: Profit ($980K, 2023-06-01), ARTFLLY ($500K, 2021-04-15), truMED ($500K, 2021-04-14), and Mindzie ($2M, 2021-01-05). Series B also appears 2 times for Renibus Therapeutics ($25M, 2023-09-12) and Onconano Medicine ($18M on 2021-10-25), while “Series Unknown” shows up 2 times for Principal Mineral ($280M, 2026-06-16) and Renegade Insurance ($75M, 2022-04-03).
Which entries look like outliers on size within this set?
Principal Mineral ($280M on 2026-06-16) is the size outlier by a wide margin. On the low end, the smallest disclosed amounts are $500K for ARTFLLY (2021-04-15) and $500K for truMED (2021-04-14), sitting far below the cluster centered around $2M–$75M.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.